
About Fresenius
Fresenius is a publicly listed company based in Bad Homburg (Germany) founded in 1912 by Eduard Fresenius. System-critical products and services for healthcare therapies are provided. Fresenius has raised $50 million across 2 funding rounds from investors including Elliott Management and DW Management Services. The company has 37 employees. Fresenius has completed 6 acquisitions, including APP Pharma, Eugin and Quirnsalud. Its chief executive, as recorded, is Stephan Sturm. Its website fresenius.com draws about 59 thousand monthly visits. Its Indian entity Fresenius Digital Technology India Private Limited reported revenue of βΉ59.73 Cr. Its focus areas include Traditional Pharmaceuticals and Diversified.
Company details
Fresenius was established in 1912 in Bad Homburg, Germany, within the healthcare sector. Operations encompass IV drugs and fluids, clinical nutrition, biopharma, transfusion and cell therapies, and infusion systems. Expansion efforts target home dialysis treatments, while digitalization is utilized to enable personalized care. In 2022, annual revenues reached 42.71B, with a net profit of 1.44B recorded. Global reach supports therapy-focused services.
- Indian entity revenue₹59.73 Cr
FY 2026 · +54% YoY
- Indian entity net profit₹5.74 Cr
FY 2026 · 10% margin
- Indian entity EBITDA₹8.25 Cr
FY 2026 · 14% margin
- Total Equity Funding$50M (USD)
in 2 rounds
- InvestorsElliott Management
& 1 more
- Employee Count37
- Investments & AcquisitionsAPP Pharma
& 5 more
Associated legal entities of Fresenius
Fresenius operates through Fresenius Digital Technology India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Fresenius Digital Technology India Private Limited CIN U74140KA2021FTC151474 | Active | 06 Sep 2021 | Bangalore, Karnataka | ₹59.7 Cr | 37 | 2 | View details |
Apps and channels of Fresenius
its YouTube channel Fresenius Group has 5.99K subscribers and 30 videos.
Videos from Fresenius
The most watched videos on Fresenius's YouTube channel, Fresenius Group (5.99K subscribers). Click a video to play it here.
More on Fresenius Group.
Funding Insights of Fresenius
Fresenius has successfully raised a total of $50M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $50M
- Total Rounds 2
- First Round $50M
(Jan 2008)
- Investors Count 2
All 2 funding rounds of Fresenius with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2022 | Post-IPO | β | β | ||
| Jan 2008 | $50M | Private Equity Round | β | β |
2 investors in total: 2 institutional.
Investors in Fresenius
Fresenius has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Elliott Management and DW Management Services.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| dwhp.com | ||||
Multiple sectors are invested in by the hedge fund. | 1977 | elliottmgmt.com | New York, United States |
Investor details for Fresenius
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Fresenius Digital Technology India Private Limited (Fresenius)
Fresenius Digital Technology India Private Limited is the primary company behind Fresenius. The board of Fresenius Digital Technology India Private Limited currently have 2 directors; the longest-serving is Ashutosh Kumar, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashutosh Kumar DIN 08030602 | Director | 06 Sep 2021 | 5 yrs 2 mo | Fresenius Digital Technology India Private Limited |
| Manish Kumar DIN 09308264 | Managing Director | 06 Sep 2021 | 5 yrs 2 mo | Fresenius Digital Technology India Private Limited |
People of Fresenius
94 people are tracked at Fresenius (45 in leadership, 13 in board & advisors, 36 in team); the tracked headcount is 37.
| Name | Role | Group |
|---|---|---|
Eduard Fresenius | Founder | Leadership |
Stephan Sturm | Co-CEO | Leadership |
Michael Sen | Co-CEO | Leadership |
Niklas Schemken | Director Corporate Strategy | Leadership |
Thomas Musseleck | Director, Head Of Risk Management Operations | Leadership |
Sara Hennicken | CFO | Leadership |
Florian Feick | Deputy Head Of Investor Relations / Head Of Equity Capital Markets (ecm) | Leadership |
Michael Otto | Director Investor Relations | Leadership |
Axel Faupel | Director Group ESG | Leadership |
Sonja Steppan | Vice President Head Research Office | Leadership |
Robert Möller | CEO Fresenius Helios | Leadership |
Elisabeth Truckenbrodt | Director Investor Relations & Sustainability | Leadership |
Katja Bajic | Director Group Controlling | Leadership |
Robert Horvath | Vice President - Strategic Finance Transformation | Leadership |
Thomas Neidert | Senior Vice President Global Treasury & Corporate Finance | Leadership |
Michael Berberich | Vice President Group Risk Management & ICS | Leadership |
Dr. Anna Lena Lieblein | VP Corporate Transformation | Leadership |
Sabine H. Scholz | Senior Vice President Internal Audit | Leadership |
Elisabeth Thäter | Head Of Employer Branding | Leadership |
Juliane Beckmann | Vice President, Head Of Corporate Finance | Leadership |
74 more people are available in the full profile.
Complete people profiles for Fresenius
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Fresenius
Fresenius is a publicly listed company on the XETR with ticker symbol FRE in Germany, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date24 Jul 1998
- Listed onFRA: FME
- Listed entityFresenius SE & Co. KGaA
- Exchange sectorHealth services
- ISINDE000FRE5EN2
- Share price43.14 EUR (+0.79% on the day) · 2026-10-14
- Market capitalisation23,863,131,215.00 EUR
- Price to earnings16.0
- EPS (diluted, trailing year)2.70 EUR
- Dividend yield2.45%
- Volume (last session)124,337
Financials of Fresenius
Figures of Fresenius Digital Technology India Private Limited, the primary company behind Fresenius, for FY 2026. Revenue was ₹59.73 Cr (+54% year on year). Net profit was ₹5.74 Cr (10% margin). EBITDA was ₹8.25 Cr (14% margin). Revenue has grown at a compounded annual rate of +65% over three years and 0% over five years.
- ₹59.73 CrRevenue · FY 2026 · +54% YoY
- ₹5.74 CrNet profit · 10% margin
- ₹8.25 CrEBITDA · 14% margin
- ₹26.5 LakhPaid-up capital
- 37Employees (provident fund records)
- +65%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 22.87B EUR | 1.26B EUR | 3.30B EUR |
| 2024 | 21.95B EUR | 471.0M EUR | 3.37B EUR |
| 2023 | 21.07B EUR | -594.0M EUR | 2.74B EUR |
| 2022 | 21.33B EUR | 1.37B EUR | 2.65B EUR |
| 2021 | 37.08B EUR | 1.82B EUR | 6.25B EUR |
Balance sheet, profit and loss, cash flow and ratios of Fresenius Digital Technology India Private Limited are on its company page.
Detailed financial statements for Fresenius
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fresenius
Fresenius has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include APP Pharma, Eugin and Quirnsalud.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Fertility treatments are delivered by standalone clinic in Barcelona. | eugin.net | Barcelona, Spain | 1999 | Dec 2020 | $525M | |
Multispecialty hospital services are provided through a network. | quironsalud.es | Madrid, Spain | 2015 | Sep 2016 | $6.42B | |
Management services for acute care healthcare providers are offered. | soundphysicians.com | Tacoma, United States | 2001 | Jun 2014 | $600M | |
Injectable pharmaceuticals are manufactured and distributed by APP Pharma. | apppharma.com | Schaumburg, United States | 2002 | Jul 2008 | $4.6B | |
Sorbents for renal replacement therapy are developed using regenerative technology. | renalsolutionsinc.com | Warrendale, United States | 2000 | Nov 2007 | $200M | |
Dialysis clinics are operated nationwide in the United States. | renalcp.com | Hollywood, United States | 2002 | May 2005 | $3.5B |
Complete acquisition details for Fresenius
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Fresenius
10 dated milestones of Fresenius across 110 years, from founding to its latest funding, stage changes and deals.
- Founded Fresenius is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Renal Care Partners.
- Acquisition Acquires Renal Solutions.
- Funding First funding round of $50.0M.
- Acquisition Acquires APP Pharma.
- Acquisition Acquires Sound Physicians.
- Acquisition Acquires Quirnsalud.
- Acquisition Acquires Eugin.
- Funding Latest funding round, Post-IPO,.
Web traffic of Fresenius
The website of Fresenius (fresenius.com) receives about 59.2K visits a month.
- Monthly visits59.2K
▲ 2.2% vs previous month
Websites whose visitors overlap most with Fresenius. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
fmc-ag.com | fmc-ag.com | 100% | β | ||
| fmcna.com | 87% | 122.1K | #184,823 | View details | |
| fresenius-kabi.com | 86% | #218,714 | View details | ||
| freseniusmedicalcare.com | 83% | 523.8K | #109,578 | View details | |
| nephrocare.com | 82% | 45.8K | #711,548 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 19 similar websites and full traffic analytics for Fresenius
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fresenius
Complete news archive for Fresenius
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fresenius
Fresenius was founded in 1912 and raised its 1st funding round 96 years after it was founded.
Fresenius is headquartered in Bad Homburg, Germany. It is registered at Bad Homburg, Hesse, Germany.
Stephan Sturm is the CEO of Fresenius, as recorded in our data.
Fresenius is a funded company, having raised a total of $50M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $50M, raised on Jan 2008.
Fresenius has 37 employees.
The primary company behind Fresenius, Fresenius Digital Technology India Private Limited, reported revenue of βΉ59.73 Cr for FY 2026, up 54% year on year.
Fresenius was established in 1912 in Bad Homburg, Germany, within the healthcare sector. Operations encompass IV drugs and fluids, clinical nutrition, biopharma, transfusion and cell therapies, and infusion systems. Expansion efforts target home dialysis treatments, while digitalization is utilized to enable personalized care. In 2022, annual revenues reached 42.71B, with a net profit of 1.44B recorded. Global reach supports therapy-focused services.
Yes, Fresenius is publicly traded on XETR under the ticker symbol FRE.
Fresenius has made 6 acquisitions, including APP Pharma, Eugin, and Quirnsalud.
Fresenius has 2 investors. Key investors include Elliott Management, and DW Management Services.
Fresenius operates through Fresenius Digital Technology India Private Limited.
The legal entities of Fresenius currently have 2 directors, including Ashutosh Kumar, Manish Kumar.
